Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): Final trial report

被引：0
|
作者：
Ahluwalia, Manmeet Singh
Ozair, Ahmad
Khosla, Atulya Aman
Patel, Neha
Elson, Paul
Murphy, Erin Sennett
Yu, Jennifer S.
Chao, Samuel T.
Suh, John H.
Stevens, Glen
Peereboom, David M.
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Cleveland Clin, Cleveland, OH USA
[3] Cleveland Clin Fdn, Solon, OH USA
[4] Cleveland Clin, Brunswick Urgent Care, Cleveland, OH USA
[5] Case Western Reserve Univ, Dept Radiat Oncol, Rose Ella Burkhart Brain Tumor & Neuro Oncol Ctr, Cleveland Clin,Lerner Coll Med, Cleveland, OH USA
[6] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH USA
[7] Cleveland Clin, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2067
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I/II trial of vorinostat combined with temozolomide (TMZ) and radiation therapy (RT) for newly diagnosed glioblastoma (GBM) (N0874-ABTC0902, Alliance): Final results of the phase I trial
    Galanis, Evanthia
    Sarkaria, Jann Nagina
    Anderson, S. Keith
    Wu, Wenting
    Jaeckle, Kurt A.
    Giannini, Caterina
    Buckner, Jan C.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] AVASTIN AND TEMOZOLOMIDE FOLLOWING RADIATION AND CHEMOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS OF A PHASE II STUDY
    Nicholas, M. K.
    Chmura, S.
    Paleologos, Nina
    Krouwer, Hendrikus
    Malkin, Mark
    Junck, Larry
    Vick, Nicholas A.
    Lukas, Rimas V.
    NEURO-ONCOLOGY, 2011, 13 : 88 - 89
  • [43] Phase Ib study of cediranib in combination with daily temozolomide and radiation in patients with newly diagnosed glioblastoma
    Chi, A. S.
    Gerstner, E. R.
    Eichler, A. F.
    Chea, H. K.
    Drappatz, J.
    Wen, P. Y.
    Ivy, S. P.
    Loeffler, J. S.
    Sorensen, A. G.
    Jain, R. K.
    Batchelor, T. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] A PHASE 0/2 'TRIGGER' TRIAL OF NIRAPARIB IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA
    Sanai, Nader
    Margaryan, Tigran
    Molloy, Jennifer
    Zhang, Hualin
    Knight, William
    Harmon, Jocelyn
    Hong, Amy
    Wanebo, John
    Kennedy, William
    Braun, Kelly
    Garcia, Michael
    Barani, Igor
    Yoo, Wonsuk
    Tien, An-Chi
    Tovmasyan, Artak
    Mehta, Shwetal
    NEURO-ONCOLOGY, 2023, 25
  • [45] Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
    Wen, Patrick Yung
    Rodon, Jordi A.
    Mason, Warren
    Beck, Joseph T.
    DeGroot, John
    Donnet, Valerie
    Mills, David
    El-Hashimy, Mona
    Rosenthal, Mark
    ESMO OPEN, 2020, 5 (04)
  • [46] Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma
    Ly, Ina
    Richardson, Leland
    Liu, Mofei
    Muzikansky, Alona
    Lou, Kevin
    Reardon, David A.
    Arrillaga-Romany, Isabel
    Forst, Deborah Anne
    Jordan, Justin T.
    Lee, Eudocia Quant
    Dietrich, Jorg
    Nayak, Lakshmi
    Wen, Patrick Y.
    Chukwueke, Ugonma Nnenna
    Giobbie-Hurder, Anita
    Choi, Bryan D.
    Batchelor, Tracy
    Kalpathy-Cramer, Jayashree
    Curry, William T.
    Gerstner, Elizabeth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Final results of a randomized phase III trial of nimotuzumab for the treatment of newly diagnosed glioblastoma in addition to standard radiation and chemotherapy with temozolomide versus standard radiation and temoziolamide
    Westphal, Manfred
    Bach, Ferdinand
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
    Lee, Eudocia Q.
    Alexander, Brian M.
    Romo, Carlos G.
    Supko, Jeffrey G.
    Agar, Nathalie Y. R.
    Talebi, Zahra
    Ahluwalia, Manmeet S.
    Desai, Arati S.
    Dietrich, Jorg
    Kaley, Thomas J.
    Peereboom, David M.
    Gantchev, Jennifer
    Baquer, Gerard
    Santagata, Sandro
    Takebe, Naoko
    Desideri, Serena
    Fisher, Joy D.
    Sims, Megan
    Ye, Xiaobu
    Ligon, Keith L.
    Nabors, Louis B.
    Grossman, Stuart A.
    Wen, Patrick Y.
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 983 - 992
  • [49] Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma
    Wen, PY
    Gigas, DC
    MacDonald, L
    Batchelor, TT
    Schiff, D
    Xu, R
    Ramakrishna, N
    Weaver, S
    Kracher, J
    Bradshaw, J
    Levy, B
    Bailey, E
    Kesari, S
    Maher, EA
    Henson, J
    Black, PM
    NEURO-ONCOLOGY, 2004, 6 (04) : 385 - 385
  • [50] JCOG0911 INTEGRA TRIAL: A RANDOMIZED SCREENING PHASE II TRIAL OF CHEMORADIOTHERAPY WITH INTERFERONβ PLUS TEMOZOLOMIDE VERSUS CHEMORADIOTHERAPY WITH TEMOZOLOMIDE ALONE FOR NEWLY-DIAGNOSED GLIOBLASTOMA
    Wakabayashi, Toshihiko
    Natsume, Atsushi
    Mizusawa, Junki
    Katayama, Hiroshi
    Fukuda, Haruhiko
    Shibui, Soichiro
    NEURO-ONCOLOGY, 2014, 16
12345